The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

The US Food and Drug Administration FDA has approved Symbravo, an oral combination of meloxicam and rizatriptan, for the ...

FDA approves Symbravo for acute migraine relief, combining rizatriptan and meloxicam. Discover its unique benefits and fast absorption for effective symptom control.

Acute renal failure occurs rapidly, causing generalized symptoms, such as nausea and confusion. It is a serious condition, but it can be treated. With proper treatment, most people can survive an ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

This study evaluates factors influencing adherence to secondary prevention medications in people with acute coronary syndrome (ACS). Methods We performed a secondary analysis of TEXT messages to ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...